soul trial oral semaglutide cardiovascular outcomes 2024 nejm results 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM soul trial oral semaglutide cardiovascular

Downstream processing is a major CDMO evaluation criterion

"So now, really, the challenge before all of us is to move much more expeditiously from evidence generation to implementation."

Weight loss injections have become increasingly prominent in the management of obesity and type 2 diabetes in the UK

We strongly encourage you to speak to a healthcare provider to assess if this type of treatment is appropriate for your unique needs

It requires insight into what is changing in real-time, not what happened last quarter

Glutathione is FDA-approved for skin whitening. Fact: The FDA has not approved glutathione for skin whitening its main use is for detoxification and antioxidant support